Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Sharp Therapeutics Corp

SHRX.V ✓ COMPLIANT ☆ Track — members

TSX Venture · Healthcare · Biotechnology & Medical Research ·

Canada Micro Cap Analyst: N/A

Last Close

$0.64

▲ +0.00%

Market Cap $20.63M · Vol 65

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$20.63M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

N/A

vs Market

52W High

$3.60

N/A below

52W Low

$0.17

N/A above

Volume

Avg 2

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

57.51%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Sharp Therapeutics Corp (SHRX.V) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SHRX.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-56.67%

-58.64%

YTD

-63.60%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-6,174,030.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-189.80% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	31.58M

Technical Indicators

50-Day SMA	$0.84
200-Day SMA	$1.58
RSI (14)	50.00
Beta	N/A
52-Week High	$3.60
52-Week Low	$0.17

Volume Today	65
Avg Daily Volume (30D)	2
Relative Volume	32.50x
Volatility (10D)	0.00
Volatility (30D)	0.00
Free Float	57.51%

Analyst Consensus

N/A

Current Price $0.64

Mean Target N/A

52W Low$0.17 52W High$3.60

Current

Target

$0.17 $3.60

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG01HR0KX60

ISINCA8200092077

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Sharp Therapeutics Corp. is a pre-clinical-stage biotechnology company developing small molecule therapies to treat genetic diseases. Its discovery platform combines high throughput screening technologies, with compound libraries computational optimized based on the physics and biology of cellular trafficking defects and allosteric activation of proteins. The platform produces small molecule compounds that restore activity in mutated proteins giving the potential to treat genetic disorders with conventional pill-based medicines. Its technology includes CoreX assay technology, AlloChem compound libraries, and mine data system and machine learning layer. Its advanced programs include a small molecule that prevents the degradation of the neuroprotective protein progranulin, thus increasing progranulin levels preventing neurodegeneration, and a small molecule that restores activity of mutated GCase protein (mutation and loss of activity of GCase is the genetic cause of Gaucher’s disease).